Dancann Pharma A/S reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was DKK 7.15 million compared to DKK 8.68 million a year ago. Net loss was DKK 12.34 million compared to DKK 16.54 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 DKK | -4.89% | -2.78% | +133.33% |
03-29 | Dancann Pharma Plans Up to DKK19 Million Rights Issue | MT |
02-28 | DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+133.33% | 1.68M | |
+5.01% | 109B | |
+11.53% | 105B | |
+0.23% | 22.25B | |
-12.22% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.05% | 16.85B | |
+4.71% | 13.76B | |
+34.95% | 12.46B |
- Stock Market
- Equities
- DANCAN Stock
- News Dancann Pharma A/S
- Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023